BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27459939)

  • 1. Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging.
    van de Haar HJ; Jansen JFA; van Osch MJP; van Buchem MA; Muller M; Wong SM; Hofman PAM; Burgmans S; Verhey FRJ; Backes WH
    Neurobiol Aging; 2016 Sep; 45():190-196. PubMed ID: 27459939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water Exchange across the Blood-Brain Barrier in Obstructive Sleep Apnea: An MRI Diffusion-Weighted Pseudo-Continuous Arterial Spin Labeling Study.
    Palomares JA; Tummala S; Wang DJ; Park B; Woo MA; Kang DW; St Lawrence KS; Harper RM; Kumar R
    J Neuroimaging; 2015; 25(6):900-5. PubMed ID: 26333175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease.
    van de Haar HJ; Burgmans S; Jansen JF; van Osch MJ; van Buchem MA; Muller M; Hofman PA; Verhey FR; Backes WH
    Radiology; 2016 Nov; 281(2):527-535. PubMed ID: 27243267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain imaging of neurovascular dysfunction in Alzheimer's disease.
    Montagne A; Nation DA; Pa J; Sweeney MD; Toga AW; Zlokovic BV
    Acta Neuropathol; 2016 May; 131(5):687-707. PubMed ID: 27038189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease.
    Wong SM; Jansen JFA; Zhang CE; Hoff EI; Staals J; van Oostenbrugge RJ; Backes WH
    Neurology; 2019 Apr; 92(15):e1669-e1677. PubMed ID: 30867275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
    Mak HK; Chan Q; Zhang Z; Petersen ET; Qiu D; Zhang L; Yau KK; Chu LW; Golay X
    J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoupling of Regional Cerebral Blood Flow and Brain Function Along the Alzheimer's Disease Continuum.
    Li J; Zeng Q; Luo X; Li K; Liu X; Hong L; Zhang X; Zhong S; Qiu T; Liu Z; Chen Y; Huang P; Zhang M;
    J Alzheimers Dis; 2023; 95(1):287-298. PubMed ID: 37483006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.
    Janik R; Thomason LA; Chaudhary S; Dorr A; Scouten A; Schwindt G; Masellis M; Stanisz GJ; Black SE; Stefanovic B
    Biochim Biophys Acta; 2016 May; 1862(5):957-65. PubMed ID: 26521151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.
    Benedictus MR; Leeuwis AE; Binnewijzend MA; Kuijer JP; Scheltens P; Barkhof F; van der Flier WM; Prins ND
    Eur Radiol; 2017 Mar; 27(3):1169-1175. PubMed ID: 27334014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal gradient during famous face naming is associated with lower cerebral blood flow and gray matter volume in aging.
    Hays CC; Zlatar ZZ; Campbell L; Meloy MJ; Wierenga CE
    Neuropsychologia; 2017 Dec; 107():76-83. PubMed ID: 29133109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Nielsen RB; Egefjord L; Angleys H; Mouridsen K; Gejl M; Møller A; Brock B; Brændgaard H; Gottrup H; Rungby J; Eskildsen SF; Østergaard L
    Alzheimers Dement; 2017 Oct; 13(10):1143-1153. PubMed ID: 28343848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder.
    Kamat PK; Kyles P; Kalani A; Tyagi N
    Mol Neurobiol; 2016 May; 53(4):2451-2467. PubMed ID: 26019015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
    Nelson AR; Sweeney MD; Sagare AP; Zlokovic BV
    Biochim Biophys Acta; 2016 May; 1862(5):887-900. PubMed ID: 26705676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D MRI of whole-brain water permeability with intrinsic diffusivity encoding of arterial labeled spin (IDEALS).
    Wengler K; Bangiyev L; Canli T; Duong TQ; Schweitzer ME; He X
    Neuroimage; 2019 Apr; 189():401-414. PubMed ID: 30682535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer's disease.
    Benedictus MR; Binnewijzend MAA; Kuijer JPA; Steenwijk MD; Versteeg A; Vrenken H; Scheltens P; Barkhof F; van der Flier WM; Prins ND
    Neurobiol Aging; 2014 Dec; 35(12):2665-2670. PubMed ID: 25018106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.
    Al-Bachari S; Parkes LM; Vidyasagar R; Hanby MF; Tharaken V; Leroi I; Emsley HC
    Neuroimage Clin; 2014; 6():1-8. PubMed ID: 25379411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease.
    Leeuwis AE; Benedictus MR; Kuijer JPA; Binnewijzend MAA; Hooghiemstra AM; Verfaillie SCJ; Koene T; Scheltens P; Barkhof F; Prins ND; van der Flier WM
    Alzheimers Dement; 2017 May; 13(5):531-540. PubMed ID: 27693109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurovascular mechanisms of Alzheimer's neurodegeneration.
    Zlokovic BV
    Trends Neurosci; 2005 Apr; 28(4):202-8. PubMed ID: 15808355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer's disease (DEBBIE-AD): a prospective observational multicohort study protocol.
    Padrela B; Mahroo A; Tee M; Sneve MH; Moyaert P; Geier O; Kuijer JPA; Beun S; Nordhøy W; Zhu YD; Buck MA; Hoinkiss DC; Konstandin S; Huber J; Wiersinga J; Rikken R; de Leeuw D; Grydeland H; Tippett L; Cawston EE; Ozturk-Isik E; Linn J; Brandt M; Tijms BM; van de Giessen EM; Muller M; Fjell A; Walhovd K; Bjørnerud A; Pålhaugen L; Selnes P; Clement P; Achten E; Anazodo U; Barkhof F; Hilal S; Fladby T; Eickel K; Morgan C; Thomas DL; Petr J; Günther M; Mutsaerts HJMM
    BMJ Open; 2024 Mar; 14(3):e081635. PubMed ID: 38458785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.